REHABILITATION OR ENHANCEMENT? FDA & THE GENE THERAPIES OF TOMORROW.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Connect Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      UNITED States. Food & Drug Administration
    • Abstract:
      The article discusses legal issues in the gene editing industry and the role played by the U.S. Food and Drug Administration (FDA) in regulating human gene editing. Also cited are the work of Chinese scientist He Jiankui on genetically engineered babies, the use of the genetic engineering tool Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), and the need to consider social risk factors in enhancement-based gene therapies.